214 related articles for article (PubMed ID: 22075670)
1. Vassopressors and inotropes.
Med Lett Drugs Ther; 2011 Nov; 53(1377):90-2. PubMed ID: 22075670
[No Abstract] [Full Text] [Related]
2. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents.
Noori S; Seri I
Clin Perinatol; 2012 Mar; 39(1):221-38. PubMed ID: 22341548
[TBL] [Abstract][Full Text] [Related]
3. The effects of vasoactive drugs on intestinal functional capillary density in endotoxemic rats: intravital video-microscopy analysis.
Nacul FE; Guia IL; Lessa MA; Tibiriçá E
Anesth Analg; 2010 Feb; 110(2):547-54. PubMed ID: 20081137
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic support and the role of dopamine.
Bellomo R; Cole L; Ronco C
Kidney Int Suppl; 1998 May; 66():S71-4. PubMed ID: 9573578
[TBL] [Abstract][Full Text] [Related]
5. Administration of inotropes.
Davies N
Nurs Times; 2001 Jul 19-25; 97(29):36-7. PubMed ID: 11957503
[No Abstract] [Full Text] [Related]
6. Use of inotropes in the critical care setting.
Löllgen H; Drexler H
Crit Care Med; 1990 Jan; 18(1 Pt 2):S56-60. PubMed ID: 2136722
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic pharmacology of intravenous vasopressors.
Kee VR
Crit Care Nurse; 2003 Aug; 23(4):79-82. PubMed ID: 12961786
[No Abstract] [Full Text] [Related]
8. Acute renal failure secondary to milrinone in a patient with cardiac amyloidosis.
Saab G; Mindel G; Ewald G; Vijayan A
Am J Kidney Dis; 2002 Aug; 40(2):E7. PubMed ID: 12148128
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular pharmacotherapy update for the intensive care unit.
Coons JC; Seidl E
Crit Care Nurs Q; 2007; 30(1):44-57. PubMed ID: 17198036
[TBL] [Abstract][Full Text] [Related]
10. Inotrope and vasopressor therapy of septic shock.
Hollenberg SM
Crit Care Clin; 2009 Oct; 25(4):781-802, ix. PubMed ID: 19892253
[TBL] [Abstract][Full Text] [Related]
11. The Use of Cardiotonic Drugs in Neonates.
Dempsey E; Rabe H
Clin Perinatol; 2019 Jun; 46(2):273-290. PubMed ID: 31010560
[TBL] [Abstract][Full Text] [Related]
12. Vasopressor therapy in critically ill patients with shock.
Russell JA
Intensive Care Med; 2019 Nov; 45(11):1503-1517. PubMed ID: 31646370
[TBL] [Abstract][Full Text] [Related]
13. What Inotrope and Why?
Phad N; de Waal K
Clin Perinatol; 2020 Sep; 47(3):529-547. PubMed ID: 32713449
[TBL] [Abstract][Full Text] [Related]
14. Recommendations for the treatment of patients with septic shock.
Meier-Hellmann A; Reinhart K
Acta Anaesthesiol Scand Suppl; 1997; 111():177-80. PubMed ID: 9421002
[No Abstract] [Full Text] [Related]
15. Use of vasopressors in the treatment of cardiac arrest.
Smith MA
Crit Care Nurs Clin North Am; 2005 Mar; 17(1):71-5, xi. PubMed ID: 15749405
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive drug support in septic shock.
Dries DJ
Shock; 2006 Nov; 26(5):529-30. PubMed ID: 17047528
[No Abstract] [Full Text] [Related]
17. Hemodynamic support in fluid-refractory pediatric septic shock.
Ceneviva G; Paschall JA; Maffei F; Carcillo JA
Pediatrics; 1998 Aug; 102(2):e19. PubMed ID: 9685464
[TBL] [Abstract][Full Text] [Related]
18. The case for adrenaline.
Myburgh JA
Crit Care Resusc; 2008 Sep; 10(3):178-9. PubMed ID: 18798710
[No Abstract] [Full Text] [Related]
19. [Postoperative cardiac care: theoretical use of various cardiovascular agents].
Sakamoto T; Suzuki A
Rinsho Kyobu Geka; 1985; 5(2):263-70. PubMed ID: 9423013
[No Abstract] [Full Text] [Related]
20. The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Belletti A; Benedetto U; Biondi-Zoccai G; Leggieri C; Silvani P; Angelini GD; Zangrillo A; Landoni G
J Crit Care; 2017 Feb; 37():91-98. PubMed ID: 27660923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
